Award details

Somatostatin receptors and brain function

ReferenceBBS/E/B/47916367
Principal Investigator / Supervisor Dr Piers Emson
Co-Investigators /
Co-Supervisors
Institution Babraham Institute
DepartmentBabraham Institute Department
Funding typeResearch
Value (£) 20,926
StatusCompleted
TypeInstitute Project
Start date 01/10/1997
End date 31/03/2000
Duration30 months

Abstract

This project aims to explore the function of somatostatin in the CNS by making and examining mice deficient in various isoforms of the somatostatin receptor. Mice are being produced in the Institute and this studentship will examine these in detail using anatomical, pharmacological and behavioural tests. Somatostatin was originally discovered as growth hormone release inhibitory factor, however subsequent work has shown that this neuropeptide is widely distributed in the CNS and may play a role in cognitive function and pain perception as well as functioning as a hypothalamic releasing factor. In the Institute in collaboration with Glaxo-Wellcome null mutant mice are being made for various somatostatin receptors. This studentship will use available tools in situ pulses/antibodies to characterise KO mice as they are developed. Pharmacological assays for receptor function (or lack of it) will be carried out in the Glaxo Institute of Applied Pharmacology, University Department of Pharmacology. The student will have the opportunity to create their own KO mouse and also to attempt to clone a human variant of one of the isoforms. The project provides a broad training in modern cellular and biological techniques.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file